New PDT Therapy for CTCL to Be Reviewed by FDA New PDT Therapy for CTCL to Be Reviewed by FDA

The treatment employs an ointment formulation of synthetic hypericin that is preferentially absorbed into malignant cells and activated with visible light, rather than ultraviolet light.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Dermatology News Source Type: news